A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis

Francesca Conradie

Isango Lethemba TB Research Unit, University of the Witwatersrand, Gqeberha, South Africa

Tasnim Badat

Isango Lethemba TB Research Unit, University of the Witwatersrand, Gqeberha, South Africa

Asanda Poswa

Isango Lethemba TB Research Unit, University of the Witwatersrand, Gqeberha, South Africa

Shakira Rajaram

Clinical HIV Research Unit, University of the Witwatersrand, Johannesburg

Shaneen Kooverjee

Clinical HIV Research Unit, University of the Witwatersrand, Johannesburg

Gary Maartens

Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa

Graeme Meintjes

Department of Medicine, University of Cape Town, Cape Town, South Africa

Jennifer Hughes

Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa

H. Simon Schaaf

Pauline Howell

Clinical HIV Research Unit, University of the Witwatersrand, Johannesburg

Norbert Ndjeka

TB Control and Management, National Department of Health, Republic of South Africa, Pretoria

Patrick P.J. Phillips

UCSF Center for Tuberculosis, University of California, San Francisco, San Francisco